A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to before ...

NEAR Protocol price analysis shows a rise to the $5.50 mark. NEAR price ROSE by over 1.2% at the time of writing. NEAR Protocol sought support and resistance at $5.50 and $6.00, respectively. Near ...